ORBEC
Live / Registered — Registered and renewed (as of 09 Jan 2024)
What this means for you
Registered since 15 Jul 2003. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 15 Jul 2023).
Record
- Serial number
- 75920960
- Registration number
- 2737267
- Mark type
- Word mark
- Filed
- 16 Feb 2000
- Published for opposition
- 28 Nov 2000
- Registered
- 15 Jul 2003
- Next maintenance due
- 15 Jul 2023
- Attorney of record
- Kari Moyer-Henry
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of graft-versus-host disease
Owner
- SOLIGENIX, INC., PRINCETON, NJ, US
- Enteron Pharmaceuticals, Inc., New York, NY, US
- Enteron Pharmaceuticals, Inc., New York, NY, US
- Enteron Pharmaceuticals, Inc., New York, NY, US
Prosecution history
- 09 Jan 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 09 Jan 2024 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 09 Jan 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 09 Jan 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 12 Jul 2023 — TEAS SECTION 8 & 9 RECEIVED
- 15 Jul 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 12 Feb 2015 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 01 Oct 2013 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 01 Oct 2013 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 01 Oct 2013 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 01 Oct 2013 — REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
- 15 Aug 2013 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 14 Aug 2013 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 17 Jul 2013 — POST REGISTRATION ACTION MAILED - SEC. 8 & 9
- 15 Jul 2013 — TEAS SECTION 8 & 9 RECEIVED